We just received data on a new analyst forecast for $HBAN. David Konrad from Keefe, Bruyette & Woods set a price target of 19.5 for HBAN.
To track analyst ratings and price targets for $HBAN, check out Quiver Quantitative's $HBAN forecast page.
Should you buy $HBAN?
Some analysts are better than others. To view the past performance of Keefe, Bruyette & Woods, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$HBAN Price Targets
Multiple analysts have issued price targets for $HBAN recently. We have seen 11 analysts offer price targets for $HBAN in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- David Konrad from Keefe, Bruyette & Woods set a target price of $19.5 on 01/23/2026
- Jason Goldberg from Barclays set a target price of $20.0 on 01/05/2026
- Jon G. Arfstrom from RBC Capital set a target price of $20.0 on 12/19/2025
- Scott Siefers from Piper Sandler set a target price of $16.0 on 12/10/2025
- Peter Winter from DA Davidson set a target price of $21.0 on 10/28/2025
- John Pancari from Evercore ISI Group set a target price of $18.0 on 10/21/2025
- David Long from Raymond James set a target price of $20.0 on 10/20/2025
$HBAN Insider Trading Activity
$HBAN insiders have traded $HBAN stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $HBAN stock by insiders over the last 6 months:
- MARCY C HINGST (SEVP and General Counsel) has made 0 purchases and 3 sales selling 60,348 shares for an estimated $1,071,186.
- HELGA HOUSTON (Senior Exec. V. P.) sold 64,587 shares for an estimated $993,348
- AMIT DHINGRA (Chief Enterprise Pmts Officer) sold 10,000 shares for an estimated $185,000
- JOHN C INGLIS purchased 6,506 shares for an estimated $99,541
- KENDALL A KOWALSKI (Chief Information Officer) has made 0 purchases and 2 sales selling 4,028 shares for an estimated $71,919.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HBAN Revenue
$HBAN had revenues of $2.2B in Q4 2025. This is an increase of 11.26% from the same period in the prior year.
You can track HBAN financials on Quiver Quantitative's HBAN stock page.
$HBAN Congressional Stock Trading
Members of Congress have traded $HBAN stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $HBAN stock by members of Congress over the last 6 months:
- SENATOR TINA SMITH sold up to $250,000 on 11/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$HBAN Hedge Fund Activity
We have seen 482 institutional investors add shares of $HBAN stock to their portfolio, and 442 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 29,357,816 shares (+1005.9%) to their portfolio in Q3 2025, for an estimated $507,009,482
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 10,590,982 shares (+66.9%) to their portfolio in Q3 2025, for an estimated $182,906,259
- FMR LLC removed 5,512,786 shares (-15.1%) from their portfolio in Q3 2025, for an estimated $95,205,814
- JUNTO CAPITAL MANAGEMENT LP added 4,961,759 shares (+inf%) to their portfolio in Q3 2025, for an estimated $85,689,577
- VICTORY CAPITAL MANAGEMENT INC added 4,640,302 shares (+15.7%) to their portfolio in Q3 2025, for an estimated $80,138,015
- UBS GROUP AG removed 4,553,948 shares (-39.7%) from their portfolio in Q3 2025, for an estimated $78,646,681
- BLACKROCK, INC. removed 4,313,179 shares (-3.0%) from their portfolio in Q3 2025, for an estimated $74,488,601
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
